Acceso abierto

Management of multiple myeloma in a patient with haemophilia with concurrent emicizumab – case report

Elizabeth Davies
Elizabeth Davies
, 
Luke Carter-Brzezinski
Luke Carter-Brzezinski
, 
Margarita Traintafillou
Margarita Traintafillou
, 
Rachel Brown
Rachel Brown
 y 
Charles R M Hay
Charles R M Hay
   | 22 dic 2021
The Journal of Haemophilia Practice's Cover Image
Acerca de este artículo
Artículo anterior
Artículo siguiente
Cite
Article Category: Case Study
Publicado en línea: 22 dic 2021
Páginas: 136 - 140
DOI: https://doi.org/10.2478/jhp-2021-0016
Palabras clave
© 2021 Elizabeth Davies et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

As people with haemophilia are living longer, there is a need to understand how to manage conditions associated with increased age, such as multiple myeloma, where standard treatment protocols involve the use of antithrombotic prophylaxis© Shutterstock
As people with haemophilia are living longer, there is a need to understand how to manage conditions associated with increased age, such as multiple myeloma, where standard treatment protocols involve the use of antithrombotic prophylaxis© Shutterstock

Figure 1

Patient history timeline
Patient history timeline
eISSN:
2055-3390
Idioma:
Inglés
Calendario de la edición:
Volume Open
Temas de la revista:
Medicine, Basic Medical Science, other, Clinical Medicine, Pharmacy, Pharmacology
RSS Feed de revista